Related Experiment Videos

Implication of a protein-tyrosine-phosphatase in human lung cancer

F Gaits1, R Y Li, A Ragab

  • 1INSERM Unité 326, Phospholipides Membranaires, Signalisation Cellulaire et Lipoprotéines, Hôpital Purpan, Toulouse, France.

Insights

Reduced expression of receptor protein tyrosine phosphatase beta (HPTP beta) mRNA in lung cancer suggests it may function as a tumor suppressor. Loss of HPTP beta may contribute to neoplastic transformation.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Protein tyrosyl phosphorylation is crucial for cellular events including proliferation and oncogenesis.
  • Protein tyrosine phosphatases (PTPases) counteract protein tyrosine kinases (PTKases), some of which are oncogenes.
  • PTPases, like HPTP gamma, may act as tumor suppressors by reversing oncogenic PTKase activity.

Purpose of the Study:

  • To investigate the role of the receptor PTPase, HPTP beta, in lung cancer.
  • To determine if HPTP beta expression is altered in lung tumor tissues and cell lines.

Main Methods:

  • Developed a semi-quantitative method using primer-directed reverse transcription (RT) and 32P-labelled polymerase chain reaction (PCR).
  • Analyzed HPTP beta mRNA expression levels in lung adenocarcinomas, lung malpighian carcinomas, and normal lung tissue.
  • Assessed HPTP beta expression in the A427 pulmonary adenocarcinoma cell line.

Main Results:

  • HPTP beta mRNA expression was significantly decreased in lung adenocarcinomas and malpighian carcinomas compared to normal lung tissue.
  • HPTP beta was not expressed in the deregulated A427 pulmonary adenocarcinoma cell line.
  • Demonstrated a dramatic reduction in HPTP beta mRNA in lung cancer samples.

Conclusions:

  • The loss of HPTP beta expression may play a role in lung cancer development.
  • HPTP beta is a potential tumor suppressor factor in lung neoplasia.
  • Further research into HPTP beta's function in lung cancer is warranted.

Related Concept Videos